PetVivo Holdings, Inc.: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 17, 2026 and accepted by EDGAR at Feb 17, 2026, 21:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-10-01 to 2025-12-31 | $286.1k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-04-01 to 2025-12-31 | $886.9k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-10-01 to 2025-12-31 | $141.4k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-04-01 to 2025-12-31 | $335.4k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-10-01 to 2025-12-31 | $144.7k | us-gaap:GrossProfit |
| Gross profit | 9 months2025-04-01 to 2025-12-31 | $551.5k | us-gaap:GrossProfit |
| Research and development | 3 months2025-10-01 to 2025-12-31 | $323.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-04-01 to 2025-12-31 | $924.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | −$2.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-04-01 to 2025-12-31 | −$6.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-10-01 to 2025-12-31 | $0 | us-gaap:InterestExpense |
| Interest expense | 9 months2025-04-01 to 2025-12-31 | $11.2k | us-gaap:InterestExpense |
| Net income | 3 months2025-10-01 to 2025-12-31 | −$2.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-04-01 to 2025-12-31 | −$7.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | −$0.07 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-04-01 to 2025-12-31 | −$0.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | −$0.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-04-01 to 2025-12-31 | −$0.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 33,674,322 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-04-01 to 2025-12-31 | 28,534,080 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-04-01 to 2025-12-31 | −$5.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-04-01 to 2025-12-31 | $7.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-12-31 | $18.2k | us-gaap:Cash |
| Current assets | At period end2025-12-31 | $1.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $4.4m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $988.4k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $997.4k | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $3.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-007150. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.